Skip to main content
Equibles
ARVN logo

ARVN · Arvinas, Inc. · Metrics

Track ARVN — free

Use ARVN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ARVN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.88 -0.02 (-0.25%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$516.55M
Shares
65.39M
Volume · Oct 30 205.9K Avg daily vol (3M) 817.13K

ARVN metrics

78 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.90
Market cap
$516.55M

Price action

20 metrics
Price change (1W)
+2.3%
Price change (30D)
+2.1%
Price change (3M)
-4.8%
Price change (6M)
-20.2%
Price change (YTD)
-33.4%
Price change (1Y)
-17.6%
Trailing year
Price change (5Y)
-90.9%
52-week high
$13.83
52-week low
$6.82
Change from 52-week high
-42.9%
Change from 52-week low
+15.8%
Annualized volatility
55.5%
Annualized volatility (3M)
52.9%
Beta
1.2
RSI (14D)
55.4
Price vs SMA 50
-2.8%
Price vs SMA 200
-18.6%
Avg volume (3M)
817,128
Relative volume
1.1
Average dollar volume
$6.77M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
65.39M

Valuation

12 metrics
P / E (TTM)
32.9
Trailing earnings · reciprocal yield 3.0%
PEG ratio
—
EV / revenue
-0.2×
EV / EBITDA
—
EV / EBIT
—
P / sales
1.6×
reciprocal yield 61.3%
P / book
0.9
reciprocal yield 108.8%
FCF yield
-40.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
1.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.1×
reciprocal yield 24.1%
EV / revenue historical average (5Y)
23.9×
reciprocal yield 4.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
-5.7%
Trailing 12 months
Net margin
2.9%
Gross profit (TTM)
—
Operating profit (TTM)
−$18.10M
Net income (TTM)
$9.30M
Trailing 12 months
Diluted EPS (TTM)
$0.24
FCF margin
-65.9%
Effective tax rate
7.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$6.83

Growth

11 metrics
Revenue growth YoY
+1,014.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$316.70M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-10.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+26.0%
Revenue CAGR (5Y)
+58.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
1.7%
Return on assets
1.4%
Debt / equity
0.0
Current ratio
7.9
EBITDA (TTM)
−$15.20M
Free cash flow (TTM)
−$208.80M
Quick ratio
7.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$567.40M
Latest balance sheet
Cash & equivalents
$94.30M
Total assets
$675.10M
Total debt
$500,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$207.00M
Capital expenditures (TTM)
$1.80M
R&D (TTM)
$238.70M
SG&A (TTM)
—
Stock compensation (TTM)
$36.70M
R&D / revenue
75.4%
Stock compensation / revenue
11.6%

Ownership (13F)

9 metrics
13F filers
201
13F filer change QoQ
-7
Institutional ownership
85.3%
Conviction holders (share of 13F filers)
0.5%
Crowding (high-turnover and private-fund holders)
34.8%
Private-fund adviser ownership
28.2%
Active holders' share change QoQ
+2.0%
Holder tenure
9.8
Price vs estimated holder cost
-25.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
14.6%

Short interest

3 metrics
Short interest
8.6%
Latest settlement · 8.2 days to cover
Days to cover
8.2d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1655759 CUSIP 04335A105 13F (30d) 37 filings 34 filers Visit website Investor relations